Ara
Toplam kayıt 1, listelenen: 1-1
Synergistic Effects of Cisplatin and Proteasome Inhibitor Bortezomib on Human Bladder Cancer Cells
(Spandidos Publ Ltd, 2015)
The proteasome inhibitor bortezomib is a promising novel agent in bladder cancer therapy; however, inducible cytoprotective mechanisms may limit its potential efficacy. To date, the cellular and molecular effects of ...